PILA PHARMA AB
556966-4831ActiveClinical stage biotech developing an oral obesity and diabetes treatment.
Oversigt
- 1–4
- Medarbejdere
- 750–999t SEK
- Omsætning
- 2014
- Grundlagt
Beskrivelse
PILA PHARMA is a clinical stage biotechnology company focused on innovative drug development. The organization is pioneering the development of XEN-D0501, an oral TRPV1-antagonist. This drug candidate is being positioned as a potential first-in-class treatment for serious conditions like obesity and...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556966483101
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrAbarceo Pharma AB
5–9 medarbejdereDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
AcroPharma AB (publ)
0 medarbejdereDeveloping innovative preventive therapeutics for major human diseases.
DiaBridge AB
0 medarbejdereDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
Synartro AB
1–4 medarbejdereDeveloping sustained local injection treatments for osteoarthritis pain relief.
Transient Pharma AB
0 medarbejdereDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Udforsk mere
Spørgsmål om PILA PHARMA AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo